The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis.

Jiantao WangSiyuan HaoJunjie GuSean G RuddYan Wang

Published in: PeerJ (2022)

Based on the findings of this study, high DSG2 expression is associated with worse prognosis in patients with NSCLC, and thus DSG2 expression could be a biomarker for prognosis in NSCLC.

Keyphrases

poor prognosis
small cell lung cancer
endothelial cells
advanced non small cell lung cancer
binding protein
long non coding rna
young adults
epidermal growth factor receptor